PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31929748-7	2020	Ruxolitinib treatment suppressed fibroblast activation and extracellular matrix (ECM) production in UUO kidneys and TGF-beta1-treated fibroblasts.	ruxolitinib	0-11	transforming growth factor, beta 1	Mus musculus	116-125	
31929748-8	2020	Ruxolitinib treatment also blocked epithelial-mesenchymal transition (EMT) in UUO kidneys and TGF-beta 1-treated renal tubular epithelial cells.	ruxolitinib	0-11	transforming growth factor, beta 1	Mus musculus	94-104